Panel Discussion | What do we Need to Consider for Adoption of New Software Devices? How can we Help Move Technologies into our Practice?

Monday, March 10, 2025

11:26 AM – 11:40 AM ET

Panel Moderator(s)

Mona Advani, M.Sc., MBA

Principal Regulatory Consultant
CardioMed Device Consultants
HERNDON, Virginia, United States

Disclosure(s): No financial relationships to disclose
Richard E. Galgon, MD, MS

Principal Consultant
CardioMed Device Consultants, LLC
Waunakee, Wisconsin, United States

Disclosure(s): No financial relationships to disclose

Panel Discussant(s)

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT

Catheterization Laboratory Director & Deputy Head of Cardiology
King Fahd Armed Forces Hospital
Jeddah, Makkah, Saudi Arabia

Disclosure(s): No financial relationships to disclose
Israel Barbash, MD

Interventional Cardiologist
Leviev Heart Center, Sheba Medical Center
Shoham, HaMerkaz, Israel

Disclosure(s): No financial relationships to disclose
Yair Feld, MD, PhD

Director -Interventional cardiology
Tzafon Medical Center (Poriya), Israel

Disclosure(s): No financial relationships to disclose
Ramzi Khamis, MB ChB PhD FRCP FESC

Consultant Cardiologist. Clinical Director of Cardiology and Cardiothoracic Surgery
Imperial College London and Imperial College Healthcare NHS Trust
London , England, United Kingdom

Disclosure(s): No financial relationships to disclose
Michael Leasure

Co-founder/President
HEARTio

Disclosure(s): Heart Input Output Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Chaim Shaul Lotan, MD

Chief Innovation Officer
Hadassah-Hebrew University Medical Center
Jerusalem, Israel

Disclosure(s): No financial relationships to disclose
Sa'ar Minha, MD

Director, Interventional Cardiology
Shamir Medical Center
Shoham, Israel

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Partha Sardar, MD

Assistant Professor
Columbia University

Disclosure(s): No financial relationships to disclose
Jason Wasfy, MD

Director of Outcomes Research
Massachusetts General Hospital
Cambridge, Massachusetts, United States

Disclosure(s): No financial relationships to disclose
Steven D. Wolff, MD, PhD

Owner
NeoSoft
Delray Beach, Florida, United States

Disclosure(s): NeoCoil: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); NeoSoft: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Disclosure(s):

Mona Advani, M.Sc., MBA: No financial relationships to disclose

Richard E. Galgon, MD, MS: No financial relationships to disclose

Mirvat Alasnag, MD, FSCAI, FACP, FACC, FSCCT: No financial relationships to disclose

Israel Barbash, MD: No financial relationships to disclose

Yair Feld, MD, PhD: No financial relationships to disclose

Ramzi Khamis, MD PhD: No financial relationships to disclose

Chaim Shaul Lotan, MD: No financial relationships to disclose

Sa'ar Minha, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Partha Sardar, MD: No financial relationships to disclose

Jason Wasfy, MD: No financial relationships to disclose

Steven D. Wolff, MD, PhD: NeoCoil: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); NeoSoft: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)